CARsgen gets a win for CAR-T in solid tumours
pharmaphorum
JANUARY 3, 2025
CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.
pharmaphorum
JANUARY 3, 2025
CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.
PharmaTimes
JANUARY 3, 2025
FDA gives green light to innovative device for liver conditions
pharmaphorum
JANUARY 3, 2025
Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.
MedCity News
JANUARY 3, 2025
Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in December appeared first on MedCity News.
Advertiser: ZoomInfo
Savvy B2B marketers know that a great account-based marketing (ABM) strategy leads to higher ROI and sustainable growth. In this guide, we’ll cover: What makes for a successful ABM strategy? What are the key elements and capabilities of ABM that can make a real difference? How is AI changing workflows and driving functionality? This Martech Intelligence Report on Enterprise Account-Based Marketing examines the state of ABM in 2024 and what to consider when implementing ABM software.
PharmaTimes
JANUARY 3, 2025
Government announces independent commission on social care
pharmaphorum
JANUARY 3, 2025
Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
JANUARY 3, 2025
Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.
European Pharmaceutical Review
JANUARY 3, 2025
Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its
pharmaphorum
JANUARY 3, 2025
Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.
Pharmaceutical Technology
JANUARY 3, 2025
Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaTech
JANUARY 3, 2025
The draft guidance document provides recommendations for complying with 21 CFR 211.110.
Pharmaceutical Commerce
JANUARY 3, 2025
A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.
Pharmaceutical Technology
JANUARY 3, 2025
SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.
Pharmaceutical Commerce
JANUARY 3, 2025
The latest news for pharma industry insiders.
Advertiser: ZoomInfo
Over the last two years, there’s been a 76 percent increase in AI adoption across sales organizations. The reason for its rise? AI increases teams’ productivity by predicting and automating actions that require manual effort. In other words, the research that takes reps hours, AI can do in seconds. For sales teams, AI opens up a world of new possibilities, including automating outreach, identifying best-fit buyers, and keeping CRMs flush with fresh data.
Pharmaceutical Technology
JANUARY 3, 2025
There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.
PharmExec
JANUARY 3, 2025
PCV21 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter a Phase III clinical trial in infants and toddlers.
Pharmaceutical Technology
JANUARY 3, 2025
China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination
PharmExec
JANUARY 3, 2025
Under terms of the deal, Johnson & Johnson will gain an exclusive license to the STAT6 program, with Kaken maintaining commercialization rights in Japan.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Commerce
JANUARY 3, 2025
In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.
PharmExec
JANUARY 3, 2025
Jennifer Hawks Bland, CEO of NewYorkBIO, shares her journey from litigation to biotech leadership, discusses fostering innovation in New York's thriving bioscience ecosystem, and outlines her vision for the state as a global biotech hub.
PharmaTech
JANUARY 3, 2025
Under the agreement, the companies will advance development of IBI3009, Innovents ADC candidate, which has received IND approvals in the US, China, and Australia.
PharmExec
JANUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertiser: ZoomInfo
Modern go-to-market teams know it takes more than one email to break through the noise. Multiple touchpoints means more ways to get your pitch right — and, potentially, more ways to be wrong. The good news? Once you know how to write compelling, one-off emails to entice prospective customers, you can easily do the same across a short sequence of emails.
pharmaphorum
JANUARY 3, 2025
The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.
PharmExec
JANUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
JANUARY 3, 2025
In an interview with Pharmaceutical Technology Roger Viney from ICE Pharma highlights the importance of sustainability for the bio/pharma industry and some important future considerations for companies.
PharmaVoice
JANUARY 3, 2025
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTech
JANUARY 3, 2025
The comment period for the Federal Register Notice, Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments, has been reopened by FDA until March 3, 2025.
PharmExec
JANUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
JANUARY 3, 2025
New medications like GLP-1 agonists and resmiterone show promise in reversing fatty liver disease and preventing progression.
PharmExec
JANUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertiser: ZoomInfo
Account-based marketing (ABM) is a key strategy for driving sustainable growth. Today, many B2B companies use ABM teams or technologies to make sales. But getting a program off the ground successfully doesn’t have to be a daunting task. Watch this webinar with Rachael Foster, Director of Account-Based Experience at ZoomInfo, and Dan Dolph, Manager of Account-Based Experience at ZoomInfo.
Let's personalize your content